Half dose ChAdOx1 nCoV-19 vaccine was equivalent to full doses to reduce moderate and severe COVID-19 cases

This publication has 16 references indexed in Scilit:

• Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study
  The Lancet Global Health, 2022
• Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil
  Nature Medicine, 2022
• Homologous and Heterologous Covid-19 Booster Vaccinations
  New England Journal of Medicine, 2022
• Estimating COVID-19 Infections, Hospitalizations, and Deaths Following the US Vaccination Campaigns During the Pandemic
  JAMA Network Open, 2022
• Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape
  Nature Reviews Immunology, 2021
• Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination
  Nature Medicine, 2021
• Heterologous vaccine regimens against COVID-19
  The Lancet, 2021
• Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice
  Nature Communications, 2021
• An acute-on-chronic health crisis in Gaza
  The Lancet, 2021
• BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
  New England Journal of Medicine, 2021